Stryker Stock Fundamentals
| SYK Stock | USD 391.07 4.08 1.03% |
Stryker fundamentals help investors to digest information that contributes to Stryker's financial success or failures. It also enables traders to predict the movement of Stryker Stock. The fundamental analysis module provides a way to measure Stryker's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stryker stock.
Stryker |
Stryker Company Return On Equity Analysis
Stryker's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Stryker Return On Equity | 0.19 |
Most of Stryker's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stryker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Stryker has a Return On Equity of 0.1887. This is 100.79% lower than that of the Health Care Equipment & Supplies sector and 102.16% lower than that of the Health Care industry. The return on equity for all United States stocks is 160.87% lower than that of the firm.
Stryker Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stryker's current stock value. Our valuation model uses many indicators to compare Stryker value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stryker competition to find correlations between indicators driving Stryker's intrinsic value. More Info.Stryker is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Stryker is roughly 2.65 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Stryker by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Stryker Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stryker's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stryker could also be used in its relative valuation, which is a method of valuing Stryker by comparing valuation metrics of similar companies.Stryker is currently under evaluation in return on equity category among its peers.
Stryker Fundamentals
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.0711 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 163.25 B | ||||
| Shares Outstanding | 381.22 M | ||||
| Shares Owned By Insiders | 5.37 % | ||||
| Shares Owned By Institutions | 80.37 % | ||||
| Number Of Shares Shorted | 4.68 M | ||||
| Price To Earning | 63.07 X | ||||
| Price To Book | 7.57 X | ||||
| Price To Sales | 6.86 X | ||||
| Revenue | 20.5 B | ||||
| Gross Profit | 14.06 B | ||||
| EBITDA | 4.93 B | ||||
| Net Income | 3.17 B | ||||
| Cash And Equivalents | 1.84 B | ||||
| Cash Per Share | 2.98 X | ||||
| Total Debt | 12.99 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 2.00 X | ||||
| Book Value Per Share | 52.85 X | ||||
| Cash Flow From Operations | 3.71 B | ||||
| Short Ratio | 3.59 X | ||||
| Earnings Per Share | 7.74 X | ||||
| Price To Earnings To Growth | 2.79 X | ||||
| Target Price | 408.49 | ||||
| Number Of Employees | 52 K | ||||
| Beta | 0.92 | ||||
| Market Capitalization | 150.64 B | ||||
| Total Asset | 39.91 B | ||||
| Retained Earnings | 16.77 B | ||||
| Working Capital | 4.6 B | ||||
| Current Asset | 1.15 B | ||||
| Current Liabilities | 707.5 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.07 % | ||||
| Net Asset | 39.91 B | ||||
| Last Dividend Paid | 3.2 |
About Stryker Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stryker's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stryker using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stryker based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. Stryker Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 46000 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Stryker Piotroski F Score and Stryker Altman Z Score analysis. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.